5. Combinational therapy: Melatonin therapy with accessory therapeutic agents
Based on the aforementioned studies we propose melatonin therapy to inhibit inflammatory cytokine secretion and alleviate atherosclerosis by regulating macrophage mitophagy. However, for optimal management of mitophagy, accessory therapeutic agents could be used alongside with melatonin therapy, forming combinational therapeutic systems.